Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Christian P. Meyer

Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study

Journal of Clinical Oncology

English

Buccal Mucosal Graft Urethroplasty for Radiation-Induced Urethral Strictures: An Evaluation Using the Extended Urethral Stricture Surgery Patient-Reported Outcome Measure (USS PROM)

World Journal of Urology

Urology

2020

English

Related publications

Genetic Polymorphisms Associated With a Prolonged Progression-Free Survival in Patients With Metastatic Renal Cell Cancer Treated With Sunitinib

Clinical Cancer Research

Cancer Research

Oncology

2010

English

Mp03-08 Comprehensive Analysis and Validation of Contemporary Survival Prognosticators in Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy

Journal of Urology

Urology

2016

English

Long-Term Survival of Pancreatic Cancer Patients Treated With Multimodal Therapy Combined With WT1-targeted Dendritic Cell Vaccines

Human Vaccines and Immunotherapeutics

English

Outcomes of Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy After Immuno-Oncology Checkpoint Inhibitors

European urology oncology

English

Mp28-09 Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma and Tumor Thrombus – Trends and Effect on Overall Survival

Journal of Urology

Urology

2018

English

Pd04-03 Survival Following Neoadjuvant Targeted Therapy and Cytoreductive Nephrectomy in MRCC Patients With Tumor Thrombus; A Contemporary Multi-Institutional Series

Journal of Urology

Urology

2017

English

Angiotensin System Inhibitors and Survival in Patients With Metastatic Renal Cell Carcinoma Treated With VEGF-targeted Therapy: A Pooled Secondary Analysis of Clinical Trials

International Journal of Cancer

Cancer Research

Oncology

2016

English

Outpatient Palliative Care Needs of Metastatic Cancer Patients Treated With Radiation Therapy

International Journal of Radiation Oncology Biology Physics

English

Immediate or Delayed Nephrectomy in Patients With Metastatic Renal Cancer Who Are Receiving Targeted Agents: Is the Analysis at Risk for Guarantee-Time Bias?

Journal of Clinical Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Christian P. Meyer

Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study

Buccal Mucosal Graft Urethroplasty for Radiation-Induced Urethral Strictures: An Evaluation Using the Extended Urethral Stricture Surgery Patient-Reported Outcome Measure (USS PROM)

Related publications

Genetic Polymorphisms Associated With a Prolonged Progression-Free Survival in Patients With Metastatic Renal Cell Cancer Treated With Sunitinib

Mp03-08 Comprehensive Analysis and Validation of Contemporary Survival Prognosticators in Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy

Long-Term Survival of Pancreatic Cancer Patients Treated With Multimodal Therapy Combined With WT1-targeted Dendritic Cell Vaccines

Outcomes of Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy After Immuno-Oncology Checkpoint Inhibitors

Mp28-09 Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma and Tumor Thrombus – Trends and Effect on Overall Survival

Pd04-03 Survival Following Neoadjuvant Targeted Therapy and Cytoreductive Nephrectomy in MRCC Patients With Tumor Thrombus; A Contemporary Multi-Institutional Series

Angiotensin System Inhibitors and Survival in Patients With Metastatic Renal Cell Carcinoma Treated With VEGF-targeted Therapy: A Pooled Secondary Analysis of Clinical Trials

Outpatient Palliative Care Needs of Metastatic Cancer Patients Treated With Radiation Therapy

Immediate or Delayed Nephrectomy in Patients With Metastatic Renal Cancer Who Are Receiving Targeted Agents: Is the Analysis at Risk for Guarantee-Time Bias?